333 related articles for article (PubMed ID: 9233604)
1. Ligation of the V7 molecule on T cells blocks anergy induction through a CD28-independent mechanism.
Soares LR; Rivas A; Tsavaler L; Engleman EG
J Immunol; 1997 Aug; 159(3):1115-24. PubMed ID: 9233604
[TBL] [Abstract][Full Text] [Related]
2. Differential response of CD4+ V7+ and CD4+ V7- T cells to T cell receptor-dependent signals: CD4+ V7+ T cells are co-stimulation independent and anti-V7 antibody blocks the induction of anergy by bacterial superantigen.
Soares LR; Rivas A; Ruegg C; Engleman EG
Eur J Immunol; 1997 Jun; 27(6):1413-21. PubMed ID: 9209493
[TBL] [Abstract][Full Text] [Related]
3. V7 (CD101) ligation inhibits TCR/CD3-induced IL-2 production by blocking Ca2+ flux and nuclear factor of activated T cell nuclear translocation.
Soares LR; Tsavaler L; Rivas A; Engleman EG
J Immunol; 1998 Jul; 161(1):209-17. PubMed ID: 9647226
[TBL] [Abstract][Full Text] [Related]
4. CD28-induced T cell activation. Evidence for a protein-tyrosine kinase signal transduction pathway.
Lu Y; Granelli-Piperno A; Bjorndahl JM; Phillips CA; Trevillyan JM
J Immunol; 1992 Jul; 149(1):24-9. PubMed ID: 1318900
[TBL] [Abstract][Full Text] [Related]
5. Evidence for the involvement of three distinct signals in the induction of IL-2 gene expression in human T lymphocytes.
June CH; Ledbetter JA; Lindsten T; Thompson CB
J Immunol; 1989 Jul; 143(1):153-61. PubMed ID: 2543699
[TBL] [Abstract][Full Text] [Related]
6. Evidence for protein tyrosine kinase involvement in CD6-induced T cell proliferation.
Osorio LM; Ordonez C; Garcia CA; Jondal M; Chow SC
Cell Immunol; 1995 Nov; 166(1):44-52. PubMed ID: 7585980
[TBL] [Abstract][Full Text] [Related]
7. CD28 is an inducible T cell surface antigen that transduces a proliferative signal in CD3+ mature thymocytes.
Turka LA; Ledbetter JA; Lee K; June CH; Thompson CB
J Immunol; 1990 Mar; 144(5):1646-53. PubMed ID: 2155264
[TBL] [Abstract][Full Text] [Related]
8. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
[TBL] [Abstract][Full Text] [Related]
9. Human T cell activation: differential response to anti-CD28 as compared to anti-CD3 monoclonal antibodies.
Bjorndahl JM; Sung SS; Hansen JA; Fu SM
Eur J Immunol; 1989 May; 19(5):881-7. PubMed ID: 2544432
[TBL] [Abstract][Full Text] [Related]
10. Functionally anergic lpr and gld B220+ T cell receptor (TCR)-alpha/beta+ double-negative T cells express CD28 and respond to costimulation with phorbol myristate acetate and antibodies to CD28 and the TCR.
Giese T; Allison JP; Davidson WF
J Immunol; 1993 Jul; 151(2):597-609. PubMed ID: 7687618
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous ligation of CD5 and CD28 on resting T lymphocytes induces T cell activation in the absence of T cell receptor/CD3 occupancy.
Verwilghen J; Vandenberghe P; Wallays G; de Boer M; Anthony N; Panayi GS; Ceuppens JL
J Immunol; 1993 Feb; 150(3):835-46. PubMed ID: 7678624
[TBL] [Abstract][Full Text] [Related]
12. Antibody and B7/BB1-mediated ligation of the CD28 receptor induces tyrosine phosphorylation in human T cells.
Vandenberghe P; Freeman GJ; Nadler LM; Fletcher MC; Kamoun M; Turka LA; Ledbetter JA; Thompson CB; June CH
J Exp Med; 1992 Apr; 175(4):951-60. PubMed ID: 1372649
[TBL] [Abstract][Full Text] [Related]
13. V7, a novel leukocyte surface protein that participates in T cell activation. I. Tissue distribution and functional studies.
Rivas A; Ruegg CL; Zeitung J; Laus R; Warnke R; Benike C; Engleman EG
J Immunol; 1995 May; 154(9):4423-33. PubMed ID: 7722299
[TBL] [Abstract][Full Text] [Related]
14. HIV gp120 inhibits T cell activation by interfering with expression of costimulatory molecules CD40 ligand and CD80 (B71).
Chirmule N; McCloskey TW; Hu R; Kalyanaraman VS; Pahwa S
J Immunol; 1995 Jul; 155(2):917-24. PubMed ID: 7541827
[TBL] [Abstract][Full Text] [Related]
15. CD45 modulates T cell receptor/CD3-induced activation of human thymocytes via regulation of tyrosine phosphorylation.
Turka LA; Kanner SB; Schieven GL; Thompson CB; Ledbetter JA
Eur J Immunol; 1992 Feb; 22(2):551-7. PubMed ID: 1371471
[TBL] [Abstract][Full Text] [Related]
16. CD4-mediated signals induce T cell dysfunction in vivo.
Chirmule N; Avots A; LakshmiTamma SM; Pahwa S; Serfling E
J Immunol; 1999 Jul; 163(2):644-9. PubMed ID: 10395653
[TBL] [Abstract][Full Text] [Related]
17. Phosphatidylinositol 3-kinase activity is not essential for CD28 costimulatory activity in Jurkat T cells: studies with a selective inhibitor, wortmannin.
Lu Y; Phillips CA; Trevillyan JM
Eur J Immunol; 1995 Feb; 25(2):533-7. PubMed ID: 7875216
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of HIV-1 Tat induced inhibition of antigen-specific T cell responsiveness.
Subramanyam M; Gutheil WG; Bachovchin WW; Huber BT
J Immunol; 1993 Mar; 150(6):2544-53. PubMed ID: 8095514
[TBL] [Abstract][Full Text] [Related]
19. CD28-induced cytokine production and proliferation by thymocytes are differentially regulated by the p59fyn tyrosine kinase.
Ong CJ; Lim AS; Teh HS
J Immunol; 1997 Sep; 159(5):2169-76. PubMed ID: 9278304
[TBL] [Abstract][Full Text] [Related]
20. CD28, IL-2-independent costimulatory pathways for CD8 T lymphocyte activation.
Sepulveda H; Cerwenka A; Morgan T; Dutton RW
J Immunol; 1999 Aug; 163(3):1133-42. PubMed ID: 10415007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
